Related Experiment Video
Updated: May 6, 2026
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
New trends in the interventional treatment of ischaemic heart disease
1Department of Medicine, Tufts University School of Medicine, Boston, MA, USA.
Insights
Direct revascularization improves coronary artery disease symptoms and prognosis. While bypass surgery and angioplasty have limitations, newer interventions and drugs like glycoprotein IIb/IIIa inhibitors show promise in reducing restenosis.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Coronary artery disease (CAD) management involves revascularization to improve blood flow.
- Coronary artery bypass surgery and balloon angioplasty are established treatments with varying efficacy and morbidity.
- Restenosis remains a significant challenge after percutaneous coronary interventions.
Purpose of the Study:
- To review current and emerging treatment options for CAD, focusing on revascularization techniques and pharmacological agents.
- To evaluate the effectiveness of various interventions and medications in reducing restenosis rates.
- To provide an overview of the landscape of coronary artery disease treatment.
Main Methods:
- Review of existing literature on coronary artery bypass surgery, balloon angioplasty, and newer interventional modalities.
- Analysis of clinical trial data for pharmacological agents, including calcium channel blockers and monoclonal antibodies.
- Meta-analysis of studies investigating the efficacy of different treatment strategies for CAD and restenosis.
Main Results:
- Balloon angioplasty shows high initial success but faces challenges with restenosis.
- Newer techniques like stenting show potential for improved restenosis rates.
- Pharmacological agents, particularly glycoprotein IIb/IIIa inhibitors, demonstrate a reduction in restenosis, while calcium channel blockers show a modest benefit in meta-analysis.
Conclusions:
- Direct revascularization is a key strategy for symptomatic relief and improved prognosis in CAD.
- Coronary stenting and specific pharmacological agents offer promising advancements in managing restenosis.
- Ongoing research into interventional and pharmacological therapies is crucial for optimizing CAD treatment outcomes.
Abstract:
Direct revascularization of an ischaemic vascular bed represents an attractive treatment option for patients with coronary artery disease. Coronary artery bypass surgery has been demonstrated to provide both symptomatic improvement and, in certain circumstances, to improve prognosis, while catheter-based techniques offer substantial improvement in symptomatology, with reduced morbidity compared with bypass surgery. Although balloon angioplasty has been associated with lesion success rates approximating to 89%, a number of anatomical substrates have proved refractory to this approach and restenosis remains a significant problem. Newer interventional modalities, such as directional atherectomy, rotablation, transluminal extraction catheterization, laser coronary angioplasty and coronary stenting, all have the potential to offer improved rates of restenosis under specific circumstances. With the exception of stents, most have not been shown to provide an overall improvement in rates of restenosis. Numerous pharmacological agents have also been investigated in an attempt to reduce levels of restenosis. Calcium channel blockers have been assessed in five trials, none of which has demonstrated a conclusive benefit, although meta-analysis of the data generated in these trials has shown a 30% reduction in the likelihood of restenosis associated with their use. More recently, monoclonal antibodies to glycoprotein IIb/IIIa have been linked to a reduction in restenosis.
Related Concept Videos
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
01:27Coronary Artery Disease V: Interprofessional Care
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:26Angina IV: Management
01:26Atherosclerosis III: Management
01:27Peripheral Artery Disease III: Interprofessional Care